SCHEMBL6471306

SCHEMBL6471306

CS(=O)(=O)C1CN(Cc2nc(Nc3ccc(C(F)(F)F)nc3)c3ncc(-c4ncccc4C(F)(F)F)cc3n2)CC(S(C)(=O)=O)O1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4975222 0.89 TRPV1 (0.84) TRPV1
SCHEMBL14283302 0.89 TRPV1 (0.84) TRPV1
SCHEMBL14283303 0.86 TRPV1 (0.69) TRPV1
SCHEMBL4973307 0.86 TRPV1 (0.69) TRPV1
SCHEMBL4972387 0.84 TRPV1 (0.83) TRPV1
SCHEMBL4971809 0.84 TRPV1 (0.68) TRPV1
SCHEMBL14283305 0.84 TRPV1 (0.68) TRPV1
SCHEMBL4973809 0.83 TRPV1 (0.67) TRPV1
SCHEMBL14283309 0.83 TRPV1 (0.67) TRPV1
SCHEMBL4971924 0.82 TRPV1 (0.66) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581225-A1 COMBINATION THERAPY FOR THE TREATMENT OF PAIN NEUROGEN CORPORATION (US) 2005-10-05 EP disclosed
WO-2004054582-A1 COMBINATION THERAPY FOR THE TREATMENT OF PAIN NEUROGEN CORPORATION (US) 2004-07-01 WO disclosed